Sign in
CompletedNo phase

DARTS I Feasibility Study

Key facts

Who runs it
Ascyrus Medical LLC.
Where
Canada5 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
40 people enrolled
Started
5 Mar 2017
Ended
19 Mar 2024
Type of study
Interventional
Treatments tested
  • AMDS
Record updated
20 August 2024

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 22 criteriaShow less

Who can take part

  • Subject must have one of the following diagnosed, based on CT angiography, within 0-14 days:
  • Acute DeBakey type I dissection or
  • Acute DeBakey type I intramural hematoma (IMH)

Who cannot take part

  • Patients must be excluded from the study if any of the following conditions are true:
  • Refusal to give informed consent; Medical Exclusion Criteria; Patients must be excluded from the study if any of the following conditions are true:
  • Uncontrolled systemic infection
  • Known allergy(ies) to Nitinol and/or PTFE
  • Previously diagnosed with Marfan syndrome, Loeys- Dietz syndrome or Ehlers- Danlos syndrome with confirmed laboratory genetic testing on a date prior to the diagnosis of the dissection; Anatomical Exclusion Criteria
  • Less than 18 years of age or over 80 years of age
  • General Exclusion Criteria
  • Life expectancy less than 2 years
  • Pregnant or breastfeeding or planning on becoming pregnant within 60 months
  • Unwilling to comply with the follow-up schedule
  • Uncontrollable anaphylaxis to iodinated contrast
  • Patient in extreme hemodynamic compromise requiring cardiopulmonary resuscitation (CPR)
  • Inability to obtain CT angiograms for follow-up
  • Any pathology of mycotic origin
  • Subacute or chronic dissection of the ascending aorta and aortic arch (>14 days after the index event)
  • Aortic fistulous communication with non-vascular structure (e.g. esophagus, bronchial)
  • Extensive thrombus or calcifications in the aortic arch as defined by CT angiography
  • Excessive tortuosity precluding safe passage of the AMDS as defined by CT angiography
  • Descending thoracic aneurysm involving the proximal third (1/3) of the descending aorta and measuring > 45mm in diameter

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The objective of this study is to investigate the feasibility and clinical benefits of the AMDS to treat patients with acute DeBakey type I dissections and/or intramural hematomas (IMH) involving the ascending aorta and aortic arch through open surgical repair.

The group in the trial

  • AMDS ImplantationTreatment being tested

    AMDS implantation is performed during an open chest procedure for intervention of aortic dissection repair.

    Treatment: AMDS

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Dissected Aorta Repair Through Stent Implantation (DARTS): A Feasibility Study
Record updated
20 August 2024